Annual Secretarial Compliance Report as per Regulation 24 A of SEBI (LODR) 2015 has been attached herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Choksi Laboratories has submitted its Annual Secretarial Compliance Report for the financial year ended 31st March 2025, as required under SEBI's Listing Regulations. The report, issued by practicing company secretary Surabhi Agrawal & Associates, confirms that the company is fully compliant with all applicable SEBI regulations, circulars, and guidelines during the review period. No penalties, fines, show-cause notices, or adverse actions were taken by SEBI or the stock exchanges against the company, its promoters, directors, or subsidiaries. All required policies under SEBI regulations have been adopted by the Board, kept up to date, and the company's website is functional with timely disclosures. Two independent directors — Mrs. Prachi Mantri and Mrs. Abha Shastri — were appointed effective April 1, 2024, with their positions regularized through postal ballot.
This is a routine annual regulatory filing with a clean compliance record, which is mildly positive for corporate governance but has no direct bearing on stock price or business performance. No material concerns or red flags were flagged for shareholders.